Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;72(12):1732-1749.
doi: 10.1111/jphp.13351. Epub 2020 Aug 12.

Recent trends in targeting miRNAs for cancer therapy

Affiliations
Review

Recent trends in targeting miRNAs for cancer therapy

Vandit Shah et al. J Pharm Pharmacol. 2020 Dec.

Abstract

Objectives: MicroRNAs (miRNAs) are a type of small noncoding RNA employed by the cells for gene regulation. A single miRNA, typically 22 nucleotides in length, can regulate the expression of numerous genes. Over the past decade, the study of miRNA biology in the context of cancer has led to the development of new diagnostic and therapeutic opportunities.

Key findings: MicroRNA dysregulation is commonly associated with cancer, in part because miRNAs are actively involved in the mechanisms like genomic instabilities, aberrant transcriptional control, altered epigenetic regulation and biogenesis machinery defects. MicroRNAs can regulate oncogenes or tumour suppressor genes and thus when altered can lead to tumorigenesis. Expression profiling of miRNAs has boosted the possibilities of application of miRNAs as potential cancer biomarkers and therapeutic targets, although the feasibility of these approaches will require further validation.

Summary: In this review, we will focus on how miRNAs regulate tumour development and the potential applications of targeting miRNAs for cancer therapy.

Keywords: cancer; cancer therapy; dysregulated expression; miRNA.

PubMed Disclaimer

References

    1. Karimi L et al. Function of microRNA-143 in different signal pathways in cancer: new insights into cancer therapy. Biomed Pharmacother 2017; 91: 121-131.
    1. Peng Y, Croce CM. The role of MicroRNAs in human cancer. Signal Transduct Target Ther 2016; 1: 15004.
    1. Garzon R et al. MicroRNAs in cancer. Annu Rev Med 2009; 60: 167-179.
    1. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
    1. Bruce JP et al. Identification of a microRNA signature associated with risk of distant metastasis in nasopharyngeal carcinoma. Oncotarget 2015; 6: 4537-4550.